News

Published on 26 Jun 2023 on Benzinga via Yahoo Finance

Biomea Fusion Stock Is Trading Higher Today - Here's Why

Article preview image

Biomea Fusion Inc (NASDAQ: BMEA) announced the presentation of new clinical data from the first two cohorts from the Phase 2 portion of its ongoing Phase 1/2 clinical study (COVALENT-111) of BMF-219 in type 2 diabetes patients.

Read the rest of the article
NASDAQ.BMEA price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Here’s Why Biomea Fusion, Inc. (NASDAQ:BMEA) Is Among the Best Diabetes Stocks...

We recently compiled a list of the 10 Best Diabetes Stocks To Buy Under $10. In this article, we ...

Insider Monkey · via Yahoo Finance 6 Jan 2025
Why Is Diabetes-Drug Developer Biomea Fusion Stock Trading Lower On Tuesday?

On Tuesday, Biomea Fusion Inc. (NASDAQ:BMEA) revealed topline results from the ongoing COVALENT-1...

Benzinga · via Yahoo Finance 17 Dec 2024
Franco Valle Bought 42% More Shares In Biomea Fusion

Even if it's not a huge purchase, we think it was good to see that Franco Valle, the CFO & Princi...

Simply Wall St. · via Yahoo Finance 18 Jun 2024
Why Are Hedge Funds Shorting Biomea Fusion, Inc. (BMEA)?

We recently compiled a list of What Is Short Selling In Stock Market? 15 Stocks Hedge Funds are S...

Insider Monkey · via Yahoo Finance 18 Jun 2024
Biomea Fusion, Inc. (NASDAQ:BMEA) Downgraded by Barclays

We recently compiled the list of the Analysts on Wall Street Lower Ratings for These 10 Stocks. I...

Insider Monkey · via Yahoo Finance 18 Jun 2024
Biomea Fusion, Inc. (BMEA): Why Did Analysts Give This Biotech Penny Stock a...

We recently compiled a list of the 10 Best Biotech Penny Stocks to Buy Now. In this article, we a...

Insider Monkey · via Yahoo Finance 18 Jun 2024
Biomea Fusion (BMEA) Stock Surges 41% in a Month: Here's Why

Biomea Fusion, Inc. BMEA, a clinical-stage company, is focused on the discovery and development o...

Zacks via Yahoo Finance 12 Dec 2023
Biomea (BMEA) Doses First Patient in Leukemia Study, Stock Up

Biomea Fusion, Inc. BMEA, a clinical-stage company, announced dosing the first patient in its ear...

Zacks via Yahoo Finance 18 Oct 2023
Is Ayr Wellness Inc. (AYRWF) Outperforming Other Medical Stocks This Year?

The Medical group has plenty of great stocks, but investors should always be looking for companie...

Zacks via Yahoo Finance 5 Oct 2023
Biomea Fusion Stock Is Trading Higher Today - Here's Why

Biomea Fusion Inc (NASDAQ: BMEA) announced the presentation of new clinical data from the first t...

Benzinga via Yahoo Finance 26 Jun 2023

Copyright Statfolio @ 2025

Social Accounts